NextCure NXTC
NASDAQ NXTC
$6.29 +0.04 (+0.64%)
At close: Aug 21, 2026 · 4:00 PM EDT

NextCure (NXTC) Other Non Operating Income (2018 - 2026)

NextCure (NXTC) posted quarterly Other Non Operating Income of $309000.0 for Q1 2026, down 52.17% year-over-year from $646000.0 in Q1 2025, and down 3.74% quarter-over-quarter from $321000.0 in Q4 2025.

NextCure (NXTC) Other Non Operating Income (2018 - 2026) Analysis & Trends

NextCure's Other Non Operating Income history runs 9 years deep, the most recent figure standing at $309000.0 for Q1 2026.

  • In Q1 2026, Other Non Operating Income fell 52.17% year-over-year to $309000.0; the TTM figure through Mar 2026 stood at $1.4 million (down 59.5% YoY), while the FY2025 annual figure was $1.8 million, down 56.72% from the prior year.
  • Other Non Operating Income for Q1 2026 stood at $309000.0, down from $321000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $1.3 million in Q4 2023, with the low at $169000.0 in Q1 2022.
  • The 5-year median for Other Non Operating Income is $646000.0 (2025), against an average of $721470.6.
  • Peak annual rise in Other Non Operating Income reached 694.29% in 2022, while the deepest fall reached 75.89% in 2022.
  • NextCure's Other Non Operating Income stood at $471000.0 in 2022, then jumped by 180.89% to $1.3 million in 2023, then sank by 35.6% to $852000.0 in 2024, then tumbled by 62.32% to $321000.0 in 2025, then fell by 3.74% to $309000.0 in 2026.
  • Business Quant data shows NXTC's Other Non Operating Income at $309000.0 in Q1 2026, $321000.0 in Q4 2025, and $321000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 NextCure 33.72 Mn 33.72 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 202,000.00
Mar 31, 2026 309,000.00
Dec 31, 2025 321,000.00
Sep 30, 2025 321,000.00
Jun 30, 2025 484,000.00
Mar 31, 2025 646,000.00
Dec 31, 2024 852,000.00
Sep 30, 2024 955,000.00
Jun 30, 2024 1.09 Mn
Mar 31, 2024 1.20 Mn
Dec 31, 2023 1.32 Mn
Sep 30, 2023 1.32 Mn
Jun 30, 2023 1.30 Mn
Mar 31, 2023 975,000.00
Dec 31, 2022 471,000.00
Sep 30, 2022 328,000.00
Jun 30, 2022 208,000.00
Mar 31, 2022 169,000.00
Dec 31, 2021 132,000.00
Sep 30, 2021 578,000.00